Persistent diarrhea: 15 years experience at a tertiary care hospital

Insights

Persistent diarrhea in children is linked to young age, lack of breastfeeding, and malnutrition. Secondary lactase deficiency is a common cause, with most cases resolving within a week of aggressive nutritional management.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Nutritional Science

Background:

  • Persistent diarrhea (PD) is a significant cause of morbidity in children.
  • Identifying risk factors and causative agents is crucial for effective management.
  • Understanding treatment outcomes informs clinical practice for pediatric PD.

Purpose of the Study:

  • To investigate risk factors associated with persistent diarrhea in children.
  • To identify common enteric pathogens responsible for PD.
  • To determine final diagnoses and evaluate treatment outcomes for PD.

Main Methods:

  • Retrospective analysis of 79 pediatric patients diagnosed with persistent diarrhea (≥14 days).
  • Exclusion of immunocompromised individuals and those with GI anomalies.
  • Review of demographic data, risk factors, enteropathogen identification, management strategies, and outcomes.

Main Results:

  • Key risk factors identified: young age (<1 year), infant formula feeding, and malnutrition (42.3% had Protein Energy Malnutrition).
  • Enteropathogens detected in 49.4% of cases, often mixed infections; secondary lactase deficiency was the primary cause in 50%.
  • Treatment involved rehydration, nutritional support, and adjuvant therapies; 70% of patients showed symptom resolution within 7 days.

Conclusions:

  • Young age, lack of breastfeeding, and malnutrition are significant risk factors for pediatric persistent diarrhea.
  • Secondary lactase deficiency is a more common cause than identified enteropathogens.
  • Aggressive nutritional management alongside standard treatment leads to rapid improvement in most PD cases.
Abstract

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
970
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
568
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
999
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
963
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
831
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
21